Fluorescence Surgery and Chemotherapy Effects on Immune Response in Brain Tumors
Part of Cancer clinical trials.
This study tests whether using special fluorescent dye during brain tumor surgery, combined with chemotherapy and radiation, helps the body's immune system fight glioblastoma (an aggressive brain cancer). Researchers will track immune markers in your blood over time to understand how these treatments work together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Good enough overall health to safely have brain surgery (no serious heart or lung disease)
- Brain tumor suspected to be glioblastoma based on imaging and clinical evaluation
- Able to attend regular follow-up appointments and MRI scans at the Lille University Hospital
- Willing to sign informed consent and follow the study schedule
- If female and able to become pregnant, must use effective birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a light-activated therapy (radiodynamic therapy) using a special medicine to help treat a brain tumor that has come back after prior treatment. It may be offered after doctors decide you need further radiation for your recurrence.
This trial tests a more intense chemotherapy plan for people with glioblastoma who had only partial removal of their tumor or whose tumor grew back quickly. The goal is to see if this approach can improve outcomes.
This trial tests a shorter, more intense course of radiation therapy (hypofractionated radiotherapy) for people with newly diagnosed glioblastoma who have had surgery. The goal is to see if this approach is safe and works well for treating the tumor.
This trial tests giving radiation and chemotherapy before surgery for glioblastoma. It aims to see if this approach is safe and may help improve outcomes for patients whose tumor can be completely removed.
This study uses special PET scans (fluciclovine and FDG) and advanced MRI to create a detailed metabolic profile of glioblastoma. It may help doctors better understand your tumor before surgery.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.